CYTOMX THERAPEUTICS INC (CTMX)
US23284F1057 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to CTMX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.39. This target is 317.96% above the current price.
CTMX was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CTMX.
In the previous month the buy percentage consensus was at a similar level.
CTMX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-06-27 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-28 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-05-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-05-09 | Wedbush | Upgrade | Neutral -> Outperform |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-06 | Jefferies | Upgrade | Hold -> Buy |
| 2024-05-01 | BMO Capital | Reiterate | Market Perform -> Market Perform |
| 2024-04-22 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-03-12 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-03-12 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-11-09 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-11-08 | Wedbush | Upgrade | Neutral -> Outperform |
| 2023-08-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023-03-28 | Mizuho | Maintains | Neutral |
| 2023-01-06 | BMO Capital | Maintains | Market Perform |
| 2022-11-14 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2022-11-10 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2022-07-11 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-07-11 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-07-07 | Mizuho | Downgrade | Buy -> Neutral |
| 2022-07-07 | BMO Capital | Maintains | Outperform |
| 2022-07-07 | BTIG | Maintains | Buy |
| 2022-07-07 | Barclays | Maintains | Overweight |
| 2022-07-07 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-07-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-07-07 | Jefferies | Downgrade | Buy -> Hold |
| 2022-06-24 | BMO Capital | Initiate | Outperform |